Table of Contents
1. Overview & Evolution of the Framework
The hallmarks of aging framework was first articulated by López-Otín, Blasco, Partridge, Serrano, and Kroemer in their landmark 2013 Cell review. The original nine hallmarks were organized hierarchically: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication.
In 2023, the same authors published an updated review expanding the framework to twelve hallmarks by adding three new entries: disabled macroautophagy, chronic inflammation, and dysbiosis. Each hallmark must satisfy three criteria: (1) it manifests during normal aging; (2) experimental aggravation accelerates aging; and (3) experimental amelioration extends healthspan or lifespan.
The twelve hallmarks are further categorized into three groups based on their relationship to aging:
- Primary hallmarks (causes of damage): genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis
- Antagonistic hallmarks (responses to damage): disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence
- Integrative hallmarks (culprit outcomes): stem cell exhaustion, altered intercellular communication, chronic inflammation, dysbiosis
2. Primary Hallmarks
Primary hallmarks are the fundamental sources of molecular and cellular damage that accumulate with age. They represent the initiating events that trigger downstream compensatory and pathological responses.
1. Genomic Instability
The progressive accumulation of DNA damage, mutations, chromosomal rearrangements, and transposable element activation that compromises genetic information integrity. Sources include reactive oxygen species, replication errors, UV radiation, and defective DNA repair. Key consequences include tumor suppressor inactivation, oncogene activation, and cellular dysfunction. The DNA damage response (DDR) is chronically activated in aging cells, contributing to senescence and inflammation.
2. Telomere Attrition
The progressive shortening of telomeric DNA with each cell division, driven by the end-replication problem and oxidative damage. When telomeres reach a critically short length, they trigger replicative senescence or apoptosis via DNA damage signaling. Telomere dysfunction also causes chromosomal instability and fusion. Read the full Telomeres entry →
3. Epigenetic Alterations
Age-associated changes in DNA methylation patterns, histone modifications, chromatin remodeling, and non-coding RNA expression. Key features include global DNA hypomethylation, focal promoter hypermethylation (particularly at tumor suppressor and DNA repair genes), altered histone marks (loss of H3K9me3 and H3K27me3), and disrupted chromatin architecture. These changes alter gene expression programs, contributing to cellular dysfunction and disease susceptibility. Read the full Epigenetic Clocks entry →
4. Loss of Proteostasis
The progressive decline in the protein quality control network, including the ubiquitin-proteasome system (UPS), autophagy-lysosome pathway, and molecular chaperones (heat shock proteins). Aging is characterized by the accumulation of misfolded, aggregated, and oxidized proteins, including amyloid-β, tau, α-synuclein, and transthyretin. Proteostasis decline contributes to neurodegenerative diseases, cataracts, and sarcopenia.
3. Antagonistic Hallmarks
Antagonistic hallmarks are compensatory responses to primary damage that are beneficial at low levels (promoting survival and stress resistance) but become deleterious when chronic or excessive.
5. Disabled Macroautophagy
The impairment of autophagy — the lysosomal degradation of damaged organelles, protein aggregates, and intracellular pathogens. Autophagy is essential for maintaining cellular homeostasis, removing dysfunctional mitochondria (mitophagy), and recycling macromolecules. With aging, autophagic flux declines due to reduced lysosomal function, impaired autophagosome-lysosome fusion, and decreased expression of autophagy genes. Caloric restriction, rapamycin, and spermidine are potent autophagy inducers that extend lifespan in model organisms.
6. Deregulated Nutrient Sensing
The disruption of metabolic signaling pathways that coordinate cellular responses to nutrient availability. Key pathways include:
- Insulin/IGF-1 signaling (IIS): Reduced IIS extends lifespan across species; mutations in IGF-1 receptor and FOXO transcription factors are associated with human longevity
- mTOR: mTORC1 integrates nutrient, energy, and growth factor signals; rapamycin inhibition extends lifespan in mice
- AMPK: The cellular energy sensor; AMPK activation mimics caloric restriction and promotes autophagy
- Sirtuins: NAD+-dependent deacetylases that regulate metabolism, DNA repair, and stress resistance; dependent on adequate NAD+ levels
7. Mitochondrial Dysfunction
The progressive decline in mitochondrial function, characterized by reduced ATP production, increased reactive oxygen species (ROS) generation, impaired mitochondrial dynamics (fusion/fission), and defective mitophagy. Mitochondrial DNA (mtDNA) mutations accumulate with age due to limited repair capacity and proximity to ROS generation. The mitochondrial unfolded protein response (UPRmt) is activated but insufficient to restore homeostasis. Mitochondrial dysfunction contributes to cellular senescence, inflammation, and tissue degeneration.
8. Cellular Senescence
The accumulation of senescent cells — cells that have undergone stable cell-cycle arrest in response to damage, stress, or telomere shortening. Senescent cells secrete the senescence-associated secretory phenotype (SASP), a pro-inflammatory, tissue-degrading mixture of cytokines, chemokines, and proteases that drives local and systemic pathology. Read the full Cellular Senescence entry →
4. Integrative Hallmarks
Integrative hallmarks are the systemic consequences of primary and antagonistic hallmarks, manifesting at the tissue, organ, and organismal levels.
9. Stem Cell Exhaustion
The decline in the number and function of tissue-resident stem cells, impairing tissue regeneration and repair. Stem cell exhaustion results from cell-intrinsic changes (telomere shortening, epigenetic alterations, DNA damage, mitochondrial dysfunction) and cell-extrinsic factors (inflammation, altered niche signaling, systemic factors). Consequences include impaired wound healing, muscle atrophy (sarcopenia), cognitive decline, and immune dysfunction (immunosenescence).
10. Altered Intercellular Communication
The disruption of signaling between cells, tissues, and organs that coordinates physiological homeostasis. Aging alters endocrine signaling (e.g., reduced growth hormone/IGF-1, altered insulin sensitivity), neuroendocrine regulation (hypothalamic dysfunction), and paracrine/juxtacrine communication. The "inflammaging" phenotype — chronic low-grade inflammation — is a key manifestation, driven by SASP, immunosenescence, and gut barrier dysfunction.
11. Chronic Inflammation (Inflammaging)
A persistent, low-grade inflammatory state characterized by elevated circulating levels of pro-inflammatory cytokines (IL-6, TNF-α, CRP), acute phase proteins, and activated immune cells. Inflammaging results from multiple sources: cellular senescence (SASP), immunosenescence, gut dysbiosis and barrier leakage, mitochondrial dysfunction, and accumulation of damaged macromolecules that activate pattern recognition receptors (PRRs). Inflammaging is a risk factor for frailty, cardiovascular disease, neurodegeneration, and cancer.
12. Dysbiosis
The age-associated alteration of the gut microbiome composition and function, characterized by reduced microbial diversity, loss of beneficial species (e.g., Bifidobacterium, Akkermansia muciniphila), and expansion of pro-inflammatory species. Dysbiosis contributes to gut barrier dysfunction ("leaky gut"), increased translocation of bacterial products (LPS) into circulation, and systemic inflammation. The gut-brain axis and gut-liver axis are particularly affected, with implications for neurodegeneration and metabolic disease.
5. Interconnections & Feedback Loops
The twelve hallmarks do not operate in isolation. Rather, they form a complex network of positive feedback loops that amplify age-related damage:
- Telomere dysfunction → senescence → SASP → inflammation: Short telomeres trigger senescence, which secretes pro-inflammatory factors that accelerate telomere shortening in neighboring cells
- Mitochondrial dysfunction → ROS → DNA damage → genomic instability: Damaged mitochondria generate ROS that damages nuclear and mitochondrial DNA, further impairing mitochondrial function
- Inflammation → insulin resistance → nutrient sensing dysregulation: Chronic inflammation impairs insulin signaling, promoting metabolic dysfunction and further inflammation
- Autophagy decline → proteostasis loss → mitochondrial dysfunction: Impaired autophagy fails to remove damaged mitochondria, accelerating energy failure and ROS production
- Dysbiosis → barrier leakage → inflammation → stem cell exhaustion: Gut-derived inflammatory signals impair stem cell niches across multiple tissues
- Epigenetic drift → telomere dysfunction + autophagy decline: Altered chromatin states affect expression of telomerase and autophagy genes
Systems Biology Perspective
Understanding aging requires a systems-level approach that accounts for these interconnections. Single-hallmark interventions (e.g., antioxidants targeting ROS, telomerase activation) have generally failed to extend lifespan, likely because compensatory mechanisms and feedback loops maintain homeostasis. Multi-hallmark interventions — such as caloric restriction, exercise, and rapamycin — may be more effective because they modulate multiple pathways simultaneously.
6. Targeting the Hallmarks
| Intervention | Hallmarks Targeted | Evidence Level | Clinical Status |
|---|---|---|---|
| Caloric restriction / fasting-mimicking diets | Nutrient sensing, autophagy, inflammation, mitochondrial function, stem cells | Strong (multiple species) | Human RCTs ongoing (CALERIE, TRIM) |
| Rapamycin / rapalogs | Nutrient sensing (mTOR), autophagy, inflammation, senescence | Strong (mice, some human data) | PEARL trial (Phase 2); off-label use debated |
| Metformin | Nutrient sensing (AMPK), inflammation, dysbiosis, proteostasis | Moderate (observational + TAME trial) | TAME trial (Phase 3, planned) |
| NAD+ precursors (NMN, NR) | Nutrient sensing (sirtuins), DNA repair, mitochondrial function, inflammation | Moderate (mixed RCT results) | Multiple Phase 2/3 trials ongoing |
| Senolytics (D+Q, fisetin) | Senescence, inflammation, stem cells | Moderate (pilot trials) | Phase 2 trials ongoing |
| Exercise | All twelve hallmarks (to varying degrees) | Strong (human RCTs) | Universally recommended |
| Probiotics / prebiotics | Dysbiosis, inflammation, nutrient sensing | Moderate (mixed results) | Widely available; strain-specific |
| Telomerase activators | Telomere attrition, senescence, stem cells | Limited (small trials) | Preclinical / early clinical |
Critical Perspective
No single intervention has been proven to extend human lifespan. The most robust evidence supports lifestyle interventions (caloric restriction, exercise, sleep optimization) as foundational. Pharmacological interventions remain experimental, with most showing modest effects on surrogate biomarkers rather than hard clinical endpoints. The field is rapidly evolving, and readers should approach commercial longevity products with skepticism pending independent scientific review.
7. References
1. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-1217.
2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278.
3. Partridge L, Deelen J, Slagboom PE. Facing up to the global challenges of ageing. Nature. 2018;561(7721):45-56.
4. Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019;571(7764):183-192.
5. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nature Reviews Cardiology. 2018;15(9):505-522.